135 related articles for article (PubMed ID: 9492192)
1. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1995 Feb; 73(1):44-51. PubMed ID: 7539402
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
4. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
5. Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2.
Tangye SG; Raison RL
Immunol Cell Biol; 1997 Apr; 75(2):127-35. PubMed ID: 9107564
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
[TBL] [Abstract][Full Text] [Related]
8. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
Francois DT; Katona IM; June CH; Wahl LM; Feuerstein N; Huang KP; Mond JJ
J Immunol; 1988 May; 140(10):3338-43. PubMed ID: 3129493
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
11. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
12. Biochemical events associated with inhibition of B-cell proliferation by phorbol diesters.
Germolec DR; Clark GC; Blank JA; Wiegand G; Luster MI
Int J Immunopharmacol; 1988; 10(8):953-65. PubMed ID: 3265131
[TBL] [Abstract][Full Text] [Related]
13. Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes.
Haas KM; Estes DM
Immunology; 2000 Feb; 99(2):272-8. PubMed ID: 10692047
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2.
Jamin C; Le Corre R; Lydyard PM; Youinou P
Eur J Immunol; 1996 Jan; 26(1):57-62. PubMed ID: 8566084
[TBL] [Abstract][Full Text] [Related]
15. Effect of 12 neutralizing anti-cytokine antibodies on in vitro activation of B-cells. Interleukin-12 is required by B1a but not B2 cells.
Jones BM
Scand J Immunol; 1996 Jan; 43(1):64-72. PubMed ID: 8560198
[TBL] [Abstract][Full Text] [Related]
16. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
Defrance T; Vanbervliet B; Durand I; Banchereau J
Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Blood; 1992 Sep; 80(5):1299-306. PubMed ID: 1381243
[TBL] [Abstract][Full Text] [Related]
18. The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation.
Maher DW; Pike BL; Boyd AW
Scand J Immunol; 1990 Dec; 32(6):631-40. PubMed ID: 1702898
[TBL] [Abstract][Full Text] [Related]
19. Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells.
Visser L; Poppema S
Br J Haematol; 1990 Jul; 75(3):359-65. PubMed ID: 2386770
[TBL] [Abstract][Full Text] [Related]
20. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
